FDA Inspection 978469 — Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited — FEI 3003157498

The FDA completed an inspection of Intas Pharmaceuticals Limited on June 17, 2016 in Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)